NDC product
Natural Relief Arthritis Therapy
NDC 17312-437 · TRP Company
Key facts
| Product NDC | 17312-437 |
|---|---|
| Proprietary name | Natural Relief Arthritis Therapy |
| Nonproprietary name | APIS MELLIFERA, SALICYLIC ACID, RUTA GRAVEOLENS, TOXICODENDRON PUBESCEN, LITHIUM CARBONATE, BRYONIA ALBA, CALCIUM FLUORIDE |
| Substances | APIS MELLIFERA, BRYONIA ALBA ROOT, CALCIUM FLUORIDE, LITHIUM CARBONATE, TOXICODENDRON PUBESCENS LEAF, RUTA GRAVEOLENS FLOWERING TOP, SALICYLIC ACID |
| Dosage form | TABLET, ORALLY DISINTEGRATING |
| Route | ORAL |
| Labeler | TRP Company |
| Product type | HUMAN OTC DRUG |
| Marketing category | UNAPPROVED HOMEOPATHIC |
| Pharmacologic classes | Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Mood Stabilizer [EPC] and 1 more |
| Marketing start | Apr 30, 2025 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: